| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Cash flows from operating activities: | | | | | | | | |
| Net earnings | 137.0 | -1,390.0 | 49.0 | 272.0 | 115.0 | 120.0 | 630.0 | -253.0 |
| Adjustments to reconcile net earnings/(loss) to net cash from operating activities: | | | | | | | | |
| Depreciation and amortization | 179.0 | 181.0 | 164.0 | 168.0 | 180.0 | 199.0 | 199.0 | 205.0 |
| Impairments and loss on sale of other investments | 29.0 | -2.0 | 1.0 | | -2.0 | | | |
| Impairments and (gain)/loss on disposal of assets, net | 286.0 | 471.0 | 1,295.0 | -2.0 | 1.0 | 69.0 | | 9.0 |
| (Gain)/Loss on sale of equity interest in naviHealth | 29.0 | -2.0 | 1.0 | | -2.0 | | | |
| Loss on early extinguishment of debt | | | | 10.0 | 13.0 | | 1.0 | |
| Share-based compensation | 16.0 | 23.0 | 18.0 | 24.0 | 5.0 | 33.0 | 23.0 | 28.0 |
| Provision for/(benefit from) deferred income taxes | | | | | | | | |
| Provision for bad debts | 22.0 | 21.0 | 13.0 | 12.0 | 16.0 | 14.0 | 19.0 | 16.0 |
| Change in operating assets and liabilities, net of effects from acquisitions and divestitures: | | | | | | | | |
| Increase in trade receivables | -333.0 | -864.0 | -115.0 | -214.0 | -393.0 | -12.0 | -111.0 | -388.0 |
| Increase in inventories | -149.0 | -561.0 | -232.0 | -129.0 | -261.0 | -67.0 | -1,011.0 | -245.0 |
| Increase in accounts payable | 2,307.0 | 62.0 | 1,351.0 | -292.0 | 1,058.0 | -594.0 | 1,548.0 | 313.0 |
| Other accrued liabilities and operating items, net | 499.0 | 1,636.0 | -1,347.0 | -495.0 | -567.0 | 515.0 | -81.0 | 585.0 |
| Net cash provided by operating activities | 2,992.0 | -419.0 | 1,195.0 | -646.0 | 665.0 | 277.0 | 1,217.0 | 270.0 |
| |
| Cash flows from investing activities: | | | | | | | | |
| Additions to property and equipment | -164.0 | -82.0 | -74.0 | -67.0 | -126.0 | -100.0 | -96.0 | -78.0 |
| Acquisition of subsidiaries, net of cash acquired | -22.0 | | | | | | -3.0 | |
| Proceeds from disposal of property and equipment | | | | | | | | |
| Purchase of other investments | -78.0 | | | | -22.0 | | | |
| Proceeds from sale of investments | | | | | | | | |
| Net cash provided by/(used in) investing activities | -204.0 | -44.0 | -47.0 | 862.0 | -88.0 | -99.0 | -97.0 | -94.0 |
| |
| Cash flows from financing activities: | | | | | | | | |
| Proceeds from interest rate swap terminations | | | | | | 18.0 | | |
| Reduction of long-term obligations | -288.0 | -5.0 | -5.0 | -587.0 | -517.0 | -4.0 | -9.0 | -40.0 |
| Dividends on common shares | -134.0 | -136.0 | -140.0 | -149.0 | -141.0 | -143.0 | -143.0 | -146.0 |
| Purchase of treasury shares | | -200.0 | -300.0 | -500.0 | | -200.0 | | |
| Net cash used in financing activities | -415.0 | -340.0 | -444.0 | -1,264.0 | -649.0 | -324.0 | -146.0 | -198.0 |
| |
| Supplemental Information: | | | | | | | | |
| Net cash payments/(refunds) for income taxes | -766.0 | | | | | | | |